You are viewing the site in preview mode
Skip to main content
| |
MCSA (Discovery)
|
MCSA (Comparison)
|
ADNI (Replication)
|
|---|
|
N = 546
|
N = 953
|
N = 545
|
|---|
|
Amyloid positive
|
Amyloid negative
|
Amyloid positive
|
|---|
|
Age (years)
|
77.0 (7.7)
|
70.0 (9.7)
|
76.1 (7.5)
|
|
Sex
|
255 (47%) women
|
430 (45%) women
|
260 (48%) women
|
|
291 (53%) men
|
523 (55%) men
|
285 (52%) men
|
|
Education (years)
|
14.6 (2.8)
|
14.9 (2.5)
|
15.9 (2.8)
|
|
Median visit number
|
4 (1.9)
|
5 (1.8)
|
4 (1.9)
|
|
APOE ɛ4 status
|
317 (58%) negative
|
756 (79%) negative
|
193 (35%) negative
|
|
229 (42%) positive
|
197 (21%) positive
|
352 (65%) positive
|
|
Diagnosisa
|
458 (85%) CU
|
887 (93%) CU
|
103 (19%) CU
|
|
78 (14%) MCI
|
62 (7%) MCI
|
223 (41%) MCI
|
|
6 (1%) Dementia
|
1 (0%) Dementia
|
214 (40%) Dementia
|
- Values displayed as mean (standard deviation) or number (percentage)
- CU cognitively unimpaired, MCI mild cognitive impairment
- aConsensus clinical diagnosis at the first PET/clinical visit; data unavailable for 4 individuals in the MCSA Discovery, 3 individuals in the MCSA Comparison, and 5 individuals in the ADNI replication samples
